Serial tumour blood-flow measurements in androgen-dependent and -independent Shionogi tumour models

BJU International

Volumn 95, Issue 4, 2005, Pages 644-649

  Kozlowski, Piotr ^a,b   Wong, Jason ^a   Goldenberg, S Larry ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood supply; Experimental animal model; Hormone dependent neoplasm; MRI

Indexed keywords

ANDROGEN;

ANDROGEN METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; CALCULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HORMONE DETERMINATION; IMAGE RECONSTRUCTION; MEASUREMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SHIONOGI TUMOR MODEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION; TUMOR BLOOD FLOW; TUMOR MODEL;

ANIMALS; BLOOD FLOW VELOCITY; CONTRAST MEDIA; FEMALE; MAGNETIC RESONANCE IMAGING; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT;

EID: 14644406928     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05355.x     Document Type: Article

References (23)

1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic environment of human tumours: a review. Cancer Res 1989; 49: 6449-65
2. Miyake H, Pollak M, Gleave ME. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-1 activity and accelerates progression to androgen independence in prostate cancer models. Cancer Res 2000; 60: 3058-64
3. Joseph IB, Nelson JB, Denmeade SR, Isaacs JT. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res 1997; 3: 2507-11
4. Jain RK, Safabakhsh N, Sckell A et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci USA 1998; 95: 10820-5
5. Bogin L, Degani H. Hormone regulation of VEGF in orthotopic MCF7 human breast cancer. Cancer Res 2002; 62: 1948-51
6. Rennie PS, Bruchovsky N, Buttyan R, Benson M, Cheng H. Gene expression during the early phases of regression of the androgen-dependent Shionogi mouse mammary carcinoma. Cancer Res 1988; 48: 6309-12
7. Bruchovsky N, Rennie PS. Classification of dependent and autonomous variants of Shionogi mammary carcinoma based on heterogenous patterns of androgen binding. Cell 1978; 13: 273-80
8. Lyng H, Dahle GA, Kaalhus O, Skretting A, Rofstad EK. Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1998; 40: 89-98
9. Kety SS. Theory of blood-tissue exchange and its applications to measurements of blood flow. Methods Med Res 1960; 8: 223-7
10. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994; 31: 567-71
11. Galbraith SM, Lodge MA, Taylor NJ et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002; 15: 132-42
12. Diesbourg LD, Prato FS, Wisenberg G et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992; 23: 239-53
13. Eskey CJ, Koretsky AP, Domach MM, Jain RK. 2H-nuclear magnetic resonance imaging of tumor blood flow, spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. Cancer Res 1992; 52 (21): 6010-9
14. Tofts PS, Brix G, Buckley DL et al. Estimating kinetic parameters from dynamic contrast enhanced T(1)-weighted MRI of diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-32
15. Kallinowski F, Schlenger KH, Runkel S et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumour xenografts. Cancer Res 1989; 49: 3759-64
16. Gillies RJ, Bhujwalla ZM, Evelhoch J et al. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2000; 2: 139-51
17. Padhani AR, MacVicar AD, Gapinski CJ et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology, 2001; 218: 365-74
18. Furman-Haran E, Margalit R, Maretzek AF, Degani H, Angiogenic response of MCF7 human breast cancer to hormonal treatment: assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution. J Magn Reson Imaging 1996; 6: 195-202
19. Jackson MW, Roberts JS, Heckford SE et al. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res 2002; 62: 854-9
20. Collado B, Gutierrez-Canas I, Rodriguez-Henche N, Prieto JC, Carmena MJ. Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells. Regul Pept 2004; 119: 69-75
21. th Meeting of ISMRM, Kyoto, Japan. May 2004: 2037
22. Hansen-Algenstaedt N, Stoll BR, Padera TP et al. Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. Cancer Res 2000; 60: 4556-60
23. Lissbrant IF, Lissbrant E, Damber JE, Bergh A, Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer. Scand J Urol Nephrol 2001; 35: 437-52